Yüklüyor......
The First Frontier: Digital Biomarkers for Neurodegenerative Disorders
Current measures of neurodegenerative diseases are highly subjective and based on episodic visits. Consequently, drug development decisions rely on sparse, subjective data, which have led to the conduct of large-scale phase 3 trials of drugs that are likely not effective. Such failures are costly, d...
Kaydedildi:
| Yayımlandı: | Digit Biomark |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7015357/ https://ncbi.nlm.nih.gov/pubmed/32095743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000477383 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|